PH27250A - The use of naphthoquinones against toxoplasmosis - Google Patents

The use of naphthoquinones against toxoplasmosis

Info

Publication number
PH27250A
PH27250A PH39415A PH39415A PH27250A PH 27250 A PH27250 A PH 27250A PH 39415 A PH39415 A PH 39415A PH 39415 A PH39415 A PH 39415A PH 27250 A PH27250 A PH 27250A
Authority
PH
Philippines
Prior art keywords
toxoplasmosis
naphthoquinones
prophylaxis
animal
compound
Prior art date
Application number
PH39415A
Other languages
English (en)
Inventor
Alan Thomas Hudson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH27250A publication Critical patent/PH27250A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH39415A 1989-09-22 1991-10-26 The use of naphthoquinones against toxoplasmosis PH27250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898921516A GB8921516D0 (en) 1989-09-22 1989-09-22 Medicaments

Publications (1)

Publication Number Publication Date
PH27250A true PH27250A (en) 1993-05-04

Family

ID=10663513

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39415A PH27250A (en) 1989-09-22 1991-10-26 The use of naphthoquinones against toxoplasmosis

Country Status (17)

Country Link
EP (1) EP0445141B1 (da)
JP (1) JP2810746B2 (da)
KR (1) KR920700626A (da)
AT (1) ATE108063T1 (da)
AU (1) AU628422B2 (da)
CA (1) CA2001568C (da)
DE (1) DE68916651T2 (da)
DK (1) DK175716B1 (da)
GB (1) GB8921516D0 (da)
HU (1) HU207942B (da)
IE (1) IE66153B1 (da)
MC (1) MC2142A1 (da)
MW (1) MW1291A1 (da)
PH (1) PH27250A (da)
SG (1) SG28346G (da)
WO (1) WO1991004021A1 (da)
ZA (1) ZA898146B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
WO2010023686A2 (en) * 2008-08-29 2010-03-04 Matrix Laboratories Limited Crystalline form of 2-chloro-3-[4-(4-chlorophenyl) cyclohexyl] [1,4]naphthoquinone, process for the same and use for producing 2-[4-(4-chlorophenyl)cyclohexyl]-3- hydroxy- 1,4- naphthoquinone
US9169232B2 (en) * 2011-09-16 2015-10-27 Alkem Laboratories Limited 3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug
CN104474416A (zh) * 2014-11-03 2015-04-01 青岛绿曼生物工程有限公司 治疗猪弓形体病的复方蜂胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
NZ230313A (en) * 1988-08-16 1992-07-28 Wellcome Found Pharmaceutical formulations comprising a naphthoquinone adapted for nasal administration, naphthoquinone derivatives, preparation and use thereof

Also Published As

Publication number Publication date
AU4519189A (en) 1991-04-18
IE893451A1 (en) 1991-03-27
GB8921516D0 (en) 1989-11-08
EP0445141A1 (en) 1991-09-11
HUT57040A (en) 1991-11-28
DE68916651D1 (de) 1994-08-11
DK93091D0 (da) 1991-05-16
MW1291A1 (en) 1991-11-13
CA2001568A1 (en) 1991-03-22
MC2142A1 (fr) 1992-02-18
JPH04504107A (ja) 1992-07-23
ZA898146B (en) 1991-06-26
HU896916D0 (en) 1991-08-28
CA2001568C (en) 1998-05-12
DE68916651T2 (de) 1995-02-16
SG28346G (en) 1995-09-18
IE66153B1 (en) 1995-12-13
ATE108063T1 (de) 1994-07-15
HU207942B (en) 1993-07-28
DK93091A (da) 1991-06-28
KR920700626A (ko) 1992-08-10
EP0445141B1 (en) 1994-07-06
AU628422B2 (en) 1992-09-17
JP2810746B2 (ja) 1998-10-15
DK175716B1 (da) 2005-01-31
WO1991004021A1 (en) 1991-04-04

Similar Documents

Publication Publication Date Title
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
DE69213010D1 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
PT95117A (pt) Metodo para o tratamento da ejaculacao precoce utilizando sertralina
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
EP0330052A3 (de) Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica
BR0016430A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
PH27250A (en) The use of naphthoquinones against toxoplasmosis
AU4519289A (en) Medicament for the treatment of cryptosporidiosis
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
BR9612316A (pt) Agente para profilaxia e tratamento de complicações diabéticas
GB9126874D0 (en) Medicaments
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
DE69307197D1 (de) Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis
PL447189A1 (pl) Nowe zastosowanie medyczne kwasu cynnabarynowego
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound